Swedish CDMO Recipharm’s growing global footprint in 2016 has positioned the company to take advantage of what is expected to be more consolidation and growth…
Takeda is letting go of 180 of the nearly 300 employees picked up in its $5.2 billion buyout of Ariad but says some of those may still land jobs in its global…
The race to snatch up generics maker Stada is heating up—and fast—with multiple players reportedly preparing to jump in, including Chinese drugmakers and,…
More than two years after buying Merck's OTC unit and local player Dihon, bringing together three separate consumer care businesses in China remains a…
Vietnam has been one of the fastest-growing economies in Asia in recent years, and Sanofi has just cut a deal to give it a stronger position in the market.
